Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.
about
Viable group A streptococci in macrophages during acute soft tissue infectionInvolvement of Streptococcal Mitogenic Exotoxin Z in Streptococcal Toxic Shock SyndromePathogenesis of group A streptococcal infectionsPersistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating womenReemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide studyGenetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseasesInverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection casesReciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo.Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies.Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen.Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner.Bacterial superantigens.Postpartum group a Streptococcus sepsis and maternal immunology.Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India.CD46 Contributes to the severity of group A streptococcal infection.Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants.Rise and persistence of global M1T1 clone of Streptococcus pyogenes.The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model.Unravelling pathogenetic mechanisms of epidemic lineages.Dynamics of the immune response against extracellular products of group A streptococci during infection.IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection.Induction of contact-dependent CD8(+) regulatory T cells through stimulation with staphylococcal and streptococcal superantigens.Lipopolysaccharide triggers invasive streptococcal disease in mice through a tumour necrosis factor-alpha-dependent mechanism.Staphylococcal enterotoxinsStreptococcal toxic shock syndrome in the intensive care unit
P2860
Q25257256-0BE0563A-E6A7-4AFA-A512-B6459F03D6E4Q27470020-E6EFA974-87EC-4A63-838B-803BF9468FA6Q29615547-82F60E3F-EFB8-4AF7-B8E2-7ED137BD9B41Q33669548-63B70FCF-25C5-4FBD-9F73-B701EF384F58Q33753208-A7C18F56-0E19-492D-A294-F28BB11AF910Q33884965-A7671AF7-D2D9-45FF-A02E-520782B4F26BQ34004799-B9238403-817B-45C0-8B68-914B80B6A922Q34005015-93F001D6-ADA8-4B70-8626-E1A419E8A31FQ34008621-2F3C9B85-86A8-49DF-BE10-32027B02193BQ35083669-E95EFE9B-98DD-4C00-B9E2-1EDA5C344ED8Q35149457-F83F550A-3950-4847-A58E-A259F43D3758Q35176156-1318DAE1-1CEC-48E4-8587-1B06EF73CC76Q35203877-949E83C2-781A-42C8-A2B3-07F30B24B6E6Q35658832-6116A2BB-9F53-4FB5-A653-51AD0E452254Q35942999-6B4A09FB-40F3-4418-8740-D920AB22A5F8Q36845102-347FA0F5-74B8-406D-920D-97A3684E7252Q37058719-BAF996A2-8DDB-46F2-88A9-82943C3AF80EQ37282916-2833B3F4-C9F2-461D-ADAF-9466CD55E145Q39968989-5DE5D3D2-DA1A-4034-82E8-64613604383DQ40207368-86317DF9-A761-42C0-B0A4-E5973CBA08AFQ42956870-9DBDDF51-EAF9-4841-B60A-DB6FC918F03EQ43181684-10E7562F-1FC9-4256-942B-9D3C84A70BEFQ53208873-7BFEFA17-6444-4EA2-89D4-A7B2EB4A8815Q54548349-11922AB2-BA5E-4507-8D07-4AF12457DB30Q56679620-78721B92-7F23-4C38-A322-F51B44016143Q58734570-17941B61-E651-4736-981B-20F16FB7B800
P2860
Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Risk factors in the pathogenes ...... f protective humoral immunity.
@ast
Risk factors in the pathogenes ...... f protective humoral immunity.
@en
Risk factors in the pathogenes ...... f protective humoral immunity.
@nl
type
label
Risk factors in the pathogenes ...... f protective humoral immunity.
@ast
Risk factors in the pathogenes ...... f protective humoral immunity.
@en
Risk factors in the pathogenes ...... f protective humoral immunity.
@nl
prefLabel
Risk factors in the pathogenes ...... f protective humoral immunity.
@ast
Risk factors in the pathogenes ...... f protective humoral immunity.
@en
Risk factors in the pathogenes ...... f protective humoral immunity.
@nl
P2093
P2860
P1476
Risk factors in the pathogenes ...... of protective humoral immunity
@en
P2093
A Norrby-Teglund
B Schwartz
O El-Ahmedy
P2860
P304
P407
P577
1999-04-01T00:00:00Z